1. Home
  2. PTCT vs MC Comparison

PTCT vs MC Comparison

Compare PTCT & MC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTCT
  • MC
  • Stock Information
  • Founded
  • PTCT 1998
  • MC 2007
  • Country
  • PTCT United States
  • MC United States
  • Employees
  • PTCT N/A
  • MC N/A
  • Industry
  • PTCT Biotechnology: Pharmaceutical Preparations
  • MC Investment Managers
  • Sector
  • PTCT Health Care
  • MC Finance
  • Exchange
  • PTCT Nasdaq
  • MC Nasdaq
  • Market Cap
  • PTCT 3.9B
  • MC 4.2B
  • IPO Year
  • PTCT 2013
  • MC 2014
  • Fundamental
  • Price
  • PTCT $52.13
  • MC $68.57
  • Analyst Decision
  • PTCT Buy
  • MC Hold
  • Analyst Count
  • PTCT 14
  • MC 7
  • Target Price
  • PTCT $67.64
  • MC $66.00
  • AVG Volume (30 Days)
  • PTCT 1.1M
  • MC 882.0K
  • Earning Date
  • PTCT 08-07-2025
  • MC 07-24-2025
  • Dividend Yield
  • PTCT N/A
  • MC 3.79%
  • EPS Growth
  • PTCT N/A
  • MC 1309.15
  • EPS
  • PTCT 7.51
  • MC 2.67
  • Revenue
  • PTCT $1,772,758,000.00
  • MC $1,384,443,000.00
  • Revenue This Year
  • PTCT $120.38
  • MC $24.90
  • Revenue Next Year
  • PTCT N/A
  • MC $17.16
  • P/E Ratio
  • PTCT $6.94
  • MC $25.67
  • Revenue Growth
  • PTCT 91.12
  • MC 42.85
  • 52 Week Low
  • PTCT $29.02
  • MC $47.00
  • 52 Week High
  • PTCT $58.38
  • MC $82.89
  • Technical
  • Relative Strength Index (RSI)
  • PTCT 62.66
  • MC 52.78
  • Support Level
  • PTCT $44.15
  • MC $69.88
  • Resistance Level
  • PTCT $52.70
  • MC $72.67
  • Average True Range (ATR)
  • PTCT 1.87
  • MC 2.00
  • MACD
  • PTCT 0.59
  • MC -0.52
  • Stochastic Oscillator
  • PTCT 93.33
  • MC 28.68

About PTCT PTC Therapeutics Inc.

PTC Therapeutics Inc is a biopharmaceutical company that discovers, develops and commercializes clinically differentiated medicines that provide benefits to children and adults living with rare disorders. Its diversified therapeutic portfolio that includes several commercial products and product candidates in various stages of development, including discovery, research and clinical stages, focused on the development of new treatments for multiple therapeutic areas for rare diseases relating to neurology and metabolism. The Company views its operations and manages its business in one operating segment: life science.

About MC Moelis & Company

Moelis & Co is an independent investment bank that provides strategic and financial advice to a diverse client base, including corporations, financial sponsors, governments, and sovereign wealth funds. The company assists its clients in achieving their strategic goals by offering comprehensive, globally integrated financial advisory services across all industry sectors. It also advises clients on their critical decisions, including mergers and acquisitions, recapitalizations and restructurings, capital markets transactions, and other corporate finance matters. it generates revenue from advisory transactions. The firm derives a majority of its revenue from the United States followed by Europe and the rest of the World.

Share on Social Networks: